Peptide Vendor Checklist: How to Evaluate Suppliers Without Brand-Naming

This site doesn't recommend specific peptide vendors. The quality landscape changes too quickly and the legal landscape varies by jurisdiction. What we can do is hand you the checklist that lets you evaluate any vendor on your own. If a supplier doesn't meet most of these, look elsewhere.

Tier 1: Documentation quality

The single most useful signal of a serious vendor is the depth of documentation they provide.

1. Per-lot Certificate of Analysis (CoA), not stock document.

The CoA must reference the specific lot you're buying. Stock CoAs that show the same data for every order are a red flag — that's marketing material, not lab work.

2. CoA includes both HPLC chromatogram and mass spec data.

HPLC purity without mass spec confirms the sample is "pure something" without confirming what. A complete CoA shows both. (See our CoA reading guide for details.)

3. Water content (Karl Fischer or TGA) reported.

Hygroscopic peptide picks up water. Quality vendors report it; cheap vendors don't measure it.

4. Counterion content reported.

Acetate or TFA percentage should be on the CoA. This affects actual peptide content per labeled milligram and matters for accurate dosing.

5. Endotoxin testing (LAL assay) on parenteral peptides.

For peptides intended for subcutaneous or IM use, look for LAL testing in EU/mg. Pharmaceutical-grade is <5 EU/mg; research-grade often skips testing entirely.

6. Independent third-party testing available.

Vendors who routinely send samples to Janoshik Analytical or similar independent labs and post the results publicly are signaling that they have nothing to hide.

Tier 2: Quality controls and synthesis

7. Synthesis source disclosure.

Vendors who tell you their peptides are synthesized at GMP-certified facilities (typically in China, India, or Western Europe) are giving you traceable supply. Vendors who claim "in-house synthesis" without further detail rarely actually synthesize peptides themselves.

8. Lot-to-lot consistency data.

A vendor that has run multiple lots of the same peptide should be able to show consistent purity across lots. Wide variation between lots suggests inconsistent quality.

9. Storage and handling documentation.

Quality vendors document the cold chain — peptide is stored cold from synthesis through packaging. Vendors who can't articulate this often don't maintain it.

10. Stability testing data.

Real shelf-life data, not marketing claims. "Stable for 24 months" should come from accelerated stability testing or real-time studies, not vendor assertion.

Tier 3: Packaging and presentation

11. Vials are clearly labeled with peptide name, lot, dose, and date.

Generic or unlabeled vials are unacceptable. The label is your reference for identity, dose, and freshness.

12. Vial caps are intact and tamper-evident.

Punctured septa or compromised seals before reconstitution mean the contents have been exposed.

13. Lyophilized cake is a fluffy white or off-white.

Yellow, brown, or hardened cake suggests degradation. Glassy or melted-looking material indicates moisture exposure during shipping.

14. Bacteriostatic water sourced separately or pharmaceutical-grade.

Some vendors include BAC water; the BAC water itself should be from a pharmaceutical source, not bulk lab-grade. If they don't include it, source it from a US compounding pharmacy.

15. Cold-chain shipping for non-lyophilized products.

Reconstituted products or temperature-sensitive peptides should arrive cold, with documentation of the shipping temperature window.

Tier 4: Communication and transparency

16. Customer support that knows the chemistry.

A real customer service contact should be able to answer basic questions about peptide stability, reconstitution, and storage. Generic e-commerce-style support is a yellow flag.

17. Returns and lot replacement policy.

Quality vendors honor lot replacements when the buyer documents quality issues (failed independent testing, visual degradation on arrival).

18. Honest regulatory framing.

Vendors who explicitly label products "for research use only" and don't make therapeutic claims are following the regulatory rules. Vendors who imply human therapeutic use are creating legal exposure for both themselves and their customers.

19. Realistic delivery times.

"Same-day shipping" claims rarely match reality. Quality vendors give honest 2–7 day shipping windows and meet them.

20. No pressure tactics on stock or pricing.

"Limited time offer" or "shortage pricing" are marketing tactics. Honest vendors don't manipulate buyers into urgency.

Tier 5: Regulatory and ethical positioning

21. No human dose recommendations on the website.

A "for research use only" peptide vendor that publishes human dosing protocols is contradicting their own legal framing. Some vendors do this anyway; it's a flag for how seriously they take the regulatory boundary.

22. No medical advice integrated into sales.

Vendor sites that include "consult a peptide specialist" sales funnels often have undisclosed business relationships with telehealth providers. Separation of supply and prescribing is cleaner.

23. Clear country of operation and regulatory jurisdiction.

Vendors that obscure where they are operating from are usually doing so for a reason — typically because they're operating in a jurisdiction that would create legal issues if disclosed.

24. No misleading "FDA approved" or "GMP" claims for research peptides.

Research peptides are not FDA approved. The synthesis facility may be GMP-certified, but that doesn't make a peptide GMP-quality once it's repackaged for research-grade sale.

25. Realistic pricing.

Peptides priced dramatically below market typically reflect either lower-quality synthesis, smaller-than-labeled doses, or substituted product. The "you pay for what you get" rule applies.

Red flags that mean walk away

• No CoA on request, or only stock CoAs
• Identical chromatograms across different lots
• Specific clinical claims ("cures X", "treats Y")
• Pressure to buy quickly
• No physical address or business contact
• Cryptocurrency-only payment (in jurisdictions where credit-card processing for peptides is available)
• Refusing to send a sample for independent testing
• Active social-media presence with influencer partnerships and no scientific content
• Claims of being "the only" or "the original" vendor of a particular peptide
• Sale of peptides like "salt forms" of GLP-1s (semaglutide sodium, etc.) — these aren't the FDA-approved active ingredient

How to actually run this checklist

For a new vendor evaluation, this is a 30-minute exercise:

1. Read their CoA for the specific peptide you're buying.
2. Check at least three peer-vendor CoAs to see how the documentation compares.
3. Send the vendor an email with two specific technical questions and see what response you get.
4. Order the smallest available unit first and send for independent testing.
5. Only commit to larger orders after you've seen the third-party results.

This costs an extra $20–50 in independent testing and 1–2 weeks of delay. Compared to the cost of a counterfeit or substandard peptide, it's a small price.

Bottom line

There's no perfect vendor and no shortcut. The vendors most worth your business are the ones whose documentation, communication, and regulatory positioning suggest they take quality seriously. The 25-point checklist above is the structure you can apply to any vendor; the answer changes as the supply chain changes.